Donate
Sheba offers one of the world’s largest and best medical centers as a place to innovate and test new ideas and technologies.
They’ve been likened to “giving patients a living drug” against cancer cells—genetically engineered T cells that selectively identify tumor cells and become super-activated upon binding to these cells. Known as […]
Read More
The agreement with Sheba Medical Center, 10th ranked hospital in the world, to be the first site for the HYLA Blood Sensor’s Clinical Study Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: […]
At a far distant point in Earth’s ancient past, two separate, single-celled life forms — an archaeon and a bacteria — became one in an act either of symbiosis or […]
The non- clinical study was conducted at The Chaim Sheba Medical Center in Israel SciSparc Ltd. (Nasdaq: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to […]
Early-stage collaboration includes the evaluation of a new virtual care regimen for managing gestational diabetes and the use of AI to develop personalized care pathways and predictive analytics Nuvo Group—the […]
Umbilical cord blood is normally thrown away at birth. But for World Autism Awareness Day on Friday, a team of doctors and scientists are calling on new mothers to collect […]
Fixed-dose OIT appeared safe and effective for younger children with high-threshold peanut allergy, according to a single-center, cross-sectional prospective study published in Annals of Allergy, Asthma & Immunology. Soad Haj […]
Pancreatic cells that produce insulin can be destroyed in overweight teens as well as adults, requiring injections of insulin, according to Sheba study. For many years, diabetologists have been saying […]
“The positive results from the first stage of this trial in such a heavily pre-treated relapsed or refractory acute myeloid leukaemia population is encouraging, especially with three of the patients […]
Findings show promise following diagnosis of impaired fasting glucose A model using routine clinical information can predict pancreatic ductal adenocarcinoma (PDA) following diagnosis of impaired fasting glucose (IFG), according to […]
